Drug Information Association Logo

Patient Engagement throughout the Full Spectrum of Drug Development: An Interactive Workshop for Life Science Companies and Patient Groups

Oct 29 2014 7:00AM - Oct 30 2014 5:00PM | Washington Marriott Wardman Park 2660 Woodley Road, NW, Washington, DC 20008 USA

« Back to Listing

Overview 

Beyond meeting efficacy and safety requirements, new medical products are increasingly expected to provide a new level of value by addressing unmet medical needs and delivering outcomes that improve quality of life in ways that are more meaningful to patients.

There is a growing awareness within medical product research and development communities that the input of the patient is needed to meet this new standard, not just as the product is marketed but from the very beginning of the development process.

Encouraged by the early efforts of some biopharmaceutical companies and patient groups, by the development of tools by PCORI, and by the example of FDA’s patient-centered drug development approach, patient groups and industry stakeholders want to work together.   Though simple in concept, the practice is complex, and all stakeholders express uncertainty about how to proceed.

This workshop will bring together regulators, industry and the full spectrum of patients to include patient groups, advocates, and caregivers to discuss their needs and objectives for engaging during the medical product development process, their methods and practices, their experiences and challenges, and their questions for each other.  Session topics and problem solving discussions will be shaped by responses from a multiple stakeholder survey, jointly administered by CTTI (Clinical Trials Transformation Initiative) and DIA, on the needs and issues of patient groups and industry and academic researchers around engagement.  Together, the workshop participants will explore more effective approaches to engagement and mutual collaboration.


 

Who Should Attend 

Individuals involved in:

  • Benefit/Risk
  • Clinical Trial Design and Conduct
  • Clinical Safety and Pharmacovigilance
  • Data Sharing
  • Drug Discovery
  • Ethics
  • Health Care Law
  • Investigators
  • Market Research
  • Medical Affairs
  • Medical Writing
  • Patient Engagement
  • Patient Advocacy
  • Quality Assurance/Quality Control
  • Regulatory Affairs
  • Strategic Planning/Research and Development
  • Study Endpoint Development

Learning Objectives 

At the conclusion of this activity, participants should be able to:

  • Recognize the benefits and importance of patient engagement throughout the medical product development life cycle
  • Explain the implications for all stakeholders of this shift in the product development paradigm
  • Discuss the perspectives and main objectives of key stakeholders (patients, patient groups, industry, and other researchers) for collaborating together throughout the product development process
  • Describe approaches to patient engagement and mutual collaboration, including: methods, tools, practices, experiences, challenges, and outcomes

Special Offers 

EARLY BIRD RATE!
DIA Industry Members who register by
October 8, 2014, save $150!


Group Discounts Available!
Register 3 and Get the 4th FREE!

Hotel & Travel 

Washington Marriott Wardman Park Hotel
A limited number of rooms are available at the reduced rate shown below (rate is guaranteed until October 6, 2014, or until room block is filled).  Please note: In order to receive the reduced room rate, hotel reservations must be made with Travel Planners and not directly with the hotel.  Contact information for Travel Planners is as follows: Attendees can follow this link to make their hotel reservations, or by calling +1.212.532.1660 or 1.800.221.3531 in the U.S. When calling please select option 1 for “Hotel Reservations,” and inform the phone agent that you are making a reservation for Event #14009.

Standard Room Rate $239 (single or double occupancy)

Hotel Address: 2660 Woodly Road NW, Washington D.C., 20008 


PLEASE READ
Warning: Unauthorized Solicitation

The most convenient airport is Washington Dulles International Airport (IAD).

Contact Information 

Printable Registration Form

Registration Questions
Toll Free 1.888.257.6457
Phone +1.215.442.6100
Fax +1.215.442.6199
Monday-Friday 8:30AM-8:00PM ET
CustomerService@diahome.org

Agenda Details
Meredith Kaganovskiy, Content Lead
Phone +1.215.442.6117
Fax +1.215.442.6199
Meredith.Kaganovskiy@diahome.org

Event Logistics
Ellen Diegel, Event Planner
Phone +1.215.293.5810
Fax +1.215.442.6199
Ellen.Diegel@diahome.org

Program Committee 

Previous Next

Agenda  

Day 1 Wednesday, Oct 29, 2014

  • 7:00AM - 8:00AM

    Registration and Continental Breakfast
  • 8:00AM - 8:30AM

    Welcome Remarks and Overview of the 2014 Patient Engagement Workshop

    Speaker(s):

    • Elizabeth Lincoln
      Global Director of Engagement
      DIA, United States
  • 8:30AM - 10:30AM

    Session 1: Profile - The Many Faces of Patients and Patient Engagement


    Session Chair(s):

    • Carl Chiang
      Director, Clinical Development
      Zinfandel Pharmaceuticals, United States

    Session 1: Profile - The Many Faces of Patients and Patient Engagement

    Speaker(s):

    • Panelists
      Research Team Invited
      United States
    • Discussion 1: Engagement, Advocacy, Patient-centric Practice - Are They the Same? What do These Endeavors Mean to Patients, to Researchers, to Regulators?
      Open Floor Discussion
      United States
    • Discussion 2: Who is the Patient? Patients and Patient Groups; Patients and Caregivers; Patients with Rare Diseases, with Chronic Disease, and with Serious Acute Disease
      Open Floor Discussion
      United States
    • Discussion 3: Patient Populations - Navigating Stages of Maturation
      Open Floor Discussion
      United States
  • 10:30AM - 11:00AM

    Refreshment Break
  • 11:00AM - 12:30PM

    Session 2: A Shared Vision for Patient Engagement: Stakeholder Needs and Expectations


    Session Chair(s):

    • Richard Klein
      Director, Patient Liaison Program, OC
      FDA, United States

    Session 2: A Shared Vision for Patient Engagement: Stakeholder Needs and Expectations

    Speaker(s):

    • Patient Groups' Perspective
      Patricia Furlong
      Founding President & CEO
      Parent Project Muscular Dystrophy, United States
    • Industry's Perspective
      Industry Speaker Invited
      United States
    • Regulators' Perspective
      FDA Speaker Invited
      United States
    • Panel Discussion
      All Session Speakers, United States
  • 12:30PM - 2:00PM

    Lunch and Round Table Discussions
  • 2:00PM - 3:30PM

    Session 3: CTTI - DIA Joint Survey: Patient and Researcher Perspectives on the Current State of Engagement


    Session Chair(s):

    • Suzanne Schrandt
      Deputy Director of Patient Engagement
      PCORI, United States

    Session 3: CTTI - DIA Joint Survey: Patient and Researcher Perspectives on the Current State of Engagement

    Speaker(s):

    • Speaker
      Speaker Invited
      United States
  • 3:30PM - 4:00PM

    Refreshment Break
  • 4:00PM - 5:30PM

    Session 4: Working Towards a Future Vision for Patient Engagement: Small Group Discussions and Report Outs on Needs and Expectations


    Session Chair(s):

    • No-image Lawrence Liberti
      Executive Director
      Centre For Innovation In Regulatory Science (CIRS), United States

    Session 4: Working Towards a Future Vision for Patient Engagement: Small Group Discussions and Report Outs on Needs and Expectations

    Speaker(s):

    • Small Group Discussions & Report Outs
      Workshop Attendees & Facilitators
      United States
  • 5:30PM - 6:30PM

    Networking Reception

Day 2 Thursday, Oct 30, 2014

  • 7:00AM - 8:00AM

    Registration and Continental Breakfast
  • 8:00AM - 8:10AM

    Welcome to Day 2
  • 8:10AM - 9:40AM

    Session 5: Patient Engagement: What is Working?


    Session Chair(s):

    • Peter Loupos, MS
      Advocacy, US Corporate Affairs
      Sanofi US, United States

    Session 5: Patient Engagement: What is Working?

    Speaker(s):

    • Case Study 1 (Open Floor Discussion to follow)
      Speaker Invited
      United States
    • Case Study 2 (Open Floor Discussion to follow)
      Speaker Invited
      United States
    • Small Group Discussions and Report Outs
      Workshop Attendees & Facilitators
      United States
  • 9:40AM - 10:00AM

    Refreshment Break
  • 10:00AM - 11:30AM

    Session 6: Patient Engagement: What's Not Working? Real World Issues


    Session Chair(s):

    • Prasun Subedi, PhD
      Pfizer Inc., United States

    Session 6: Patient Engagement: What's Not Working? Real World Issues

    Speaker(s):

    • Problematic/Difficult Issues Example 1 (Open Floor Discussion to follow)
      Speaker Invited
      United States
    • Problematic/Difficult Issues Example 2 (Open Floor Discussion to follow)
      Speaker Invited
      United States
  • 11:30AM - 1:00PM

    Lunch
  • 1:00PM - 3:30PM

    Session 7: Patient Engagement: How Can We Improve?


    Session Chair(s):

    • Marcia K. Horn, JD
      President and Chief Executive Officer
      International Cancer Advocacy Network (ICAN), United States

    Session 7: Patient Engagement: How Can We Improve?

    Speaker(s):

    • Small Group Discussions & Report Outs
      Workshop Attendees & Facilitators
      United States
  • 3:30PM - 4:30PM

    Session 8: The Future of Patient and Researcher Engagement: What Does Collaboration Look Like?


    Session Chair(s):

    • Lona Vincent, MPH
      Senior Associate Director
      Michael J. Fox Foundation For Parkinson's Research, United States

    Session 8: The Future of Patient and Researcher Engagement: What Does Collaboration Look Like?

    Speaker(s):

    • Speakers
      Additional Speakers Invited
      United States

Registration Fees 

Member

Member Government
$630.00
Member Academia
$785.00
Member Individual
$1420.00
Member Individual (As of 10/09/2014)
$1570.00

Non-Member

NonMember Government
$855.00
NonMember Academia
$1010.00
NonMember Individual
$1795.00
Group Discounts

Register three individuals from the same company and receive complimentary registration for a fourth! All four individuals must register and prepay at the same time – no exceptions. DIA will apply the value of the lowest applicable fee to this complimentary registration; it does NOT include fees for optional events or DIA membership. You may substitute group participants of the same membership status at any time; however, administrative fees may be incurred.

Group registration is not available online and does not apply to the already-discounted fees for government or charitable nonprofit/academia. To take advantage of this offer, please print a registration form for EACH of the four registrants from your company. Include the names of all four group registrants on each of the forms and return them together to DIA.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top